Danaher ROE 2010-2024 | DHR

Current and historical return on equity (ROE) values for Danaher (DHR) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Danaher ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-12-31 $3.90B $49.55B 7.64%
2024-09-30 $3.89B $51.31B 7.48%
2024-06-30 $4.20B $49.90B 8.03%
2024-03-31 $4.40B $53.45B 8.34%
2023-12-31 $4.74B $53.49B 9.07%
2023-09-30 $5.87B $52.42B 11.42%
2023-06-30 $6.30B $51.72B 12.57%
2023-03-31 $6.85B $51.49B 14.03%
2022-12-31 $7.10B $50.09B 14.95%
2022-09-30 $6.64B $46.99B 14.35%
2022-06-30 $6.21B $46.60B 13.67%
2022-03-31 $6.29B $46.36B 14.16%
2021-12-31 $6.27B $45.18B 14.59%
2021-09-30 $5.72B $43.46B 13.75%
2021-06-30 $5.45B $42.77B 13.54%
2021-03-31 $4.60B $40.43B 11.90%
2020-12-31 $3.51B $39.78B 9.68%
2020-09-30 $3.57B $37.97B 10.52%
2020-06-30 $3.37B $36.27B 10.31%
2020-03-31 $3.19B $31.07B 10.06%
2019-12-31 $2.94B $30.28B 9.24%
2019-09-30 $2.43B $33.20B 7.77%
2019-06-30 $2.45B $32.21B 8.18%
2019-03-31 $2.41B $31.57B 8.41%
2018-12-31 $2.65B $28.23B 9.61%
2018-09-30 $2.76B $27.69B 10.18%
2018-06-30 $2.67B $27.22B 10.06%
2018-03-31 $2.55B $27.20B 9.86%
2017-12-31 $2.49B $26.37B 9.95%
2017-09-30 $2.38B $25.38B 9.84%
2017-06-30 $2.20B $24.60B 9.30%
2017-03-31 $2.30B $23.79B 9.67%
2016-12-31 $2.55B $23.08B 10.64%
2016-09-30 $2.50B $23.26B 10.32%
2016-06-30 $3.51B $25.12B 14.51%
2016-03-31 $3.55B $24.58B 14.82%
2015-12-31 $3.36B $23.76B 14.21%
2015-09-30 $3.33B $23.18B 14.14%
2015-06-30 $2.61B $24.17B 11.01%
2015-03-31 $2.59B $23.39B 10.97%
2014-12-31 $2.60B $23.45B 11.05%
2014-09-30 $2.73B $23.81B 11.71%
2014-06-30 $2.64B $23.79B 11.66%
2014-03-31 $2.58B $23.03B 11.85%
2013-12-31 $2.70B $22.45B 12.84%
2013-09-30 $2.54B $21.37B 12.59%
2013-06-30 $2.49B $20.37B 12.73%
2013-03-31 $2.47B $19.75B 12.98%
2012-12-31 $2.39B $19.08B 12.88%
2012-09-30 $2.33B $18.95B 12.93%
2012-06-30 $2.31B $18.37B 13.22%
2012-03-31 $2.36B $17.89B 13.86%
2011-12-31 $2.17B $16.97B 13.40%
2011-09-30 $2.08B $16.56B 13.47%
2011-06-30 $2.20B $16.56B 15.10%
2011-03-31 $1.92B $14.72B 14.30%
2010-12-31 $1.79B $13.77B 14.09%
2010-09-30 $1.59B $13.17B 13.02%
2010-06-30 $1.29B $12.06B 11.04%
2010-03-31 $1.21B $11.85B 10.72%
2009-12-31 $1.15B $11.63B 10.61%
Sector Industry Market Cap Revenue
Medical Medical Services $151.685B $23.875B
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $90.559B 11.84
Cencora (COR) United States $47.572B 17.32
Natera (NTRA) United States $23.122B 0.00
DiDi Global (DIDIY) China $22.844B 0.00
ICON (ICLR) Ireland $16.164B 14.40
Avantor (AVTR) United States $14.769B 22.14
Revvity (RVTY) United States $14.502B 24.32
BioMerieux (BMXMF) France $14.256B 0.00
Viatris (VTRS) United States $13.010B 4.01
Solventum (SOLV) United States $12.919B 0.00
CochLear (CHEOY) Australia $12.848B 0.00
Medpace Holdings (MEDP) United States $11.220B 31.61
Doximity (DOCS) United States $10.877B 56.56
EUROFINS SCIENT (ERFSF) Luxembourg $10.037B 0.00
HealthEquity (HQY) United States $9.712B 48.73
Sonic Healthcare (SKHHY) Australia $8.513B 0.00
Charles River Laboratories (CRL) United States $8.502B 16.43
Amplifon S.p.A (AMFPF) Italy $6.136B 31.28
Bausch + Lomb (BLCO) Canada $5.661B 26.33
BrightSpring Health Services (BTSG) United States $3.913B 83.22
Sotera Health (SHC) United States $3.909B 20.91
Organon (OGN) United States $3.835B 3.87
Surgery Partners (SGRY) United States $3.260B 37.17
Concentras Parent (CON) United States $2.958B 0.00
Alignment Healthcare (ALHC) United States $2.885B 0.00
PACS (PACS) United States $2.161B 0.00
Ardent Health Partners (ARDT) United States $2.121B 0.00
Teladoc Health (TDOC) United States $2.061B 0.00
Progyny (PGNY) United States $1.859B 37.64
GoodRx Holdings (GDRX) United States $1.837B 48.20
Premier (PINC) United States $1.821B 11.08
GeneDx Holdings (WGS) United States $1.708B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.409B 0.00
Agilon Health (AGL) United States $1.351B 0.00
CareDx (CDNA) United States $1.217B 0.00
Pediatrix Medical (MD) United States $1.177B 11.51
Embecta (EMBC) United States $1.031B 7.06
AMN Healthcare Services Inc (AMN) United States $0.993B 6.72
Establishment Labs Holdings (ESTA) $0.848B 0.00
Auna S.A (AUNA) Luxembourg $0.602B 0.00
SBC Medicals (SBC) United States $0.533B 0.00
DocGo (DCGO) United States $0.501B 18.89
Sonida Senior Living (SNDA) United States $0.464B 0.00
InnovAge Holding (INNV) United States $0.435B 0.00
Enhabit (EHAB) United States $0.414B 35.83
QDM (QDMI) Hong Kong, SAR China $0.382B 10.00
MultiPlan (MPLN) United States $0.352B 0.00
Nutex Health (NUTX) United States $0.323B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.317B 0.00
LifeMD (LFMD) United States $0.270B 0.00
Beauty Health (SKIN) United States $0.201B 0.00
Performant Healthcare (PHLT) United States $0.185B 0.00
Sera Prognostics (SERA) United States $0.159B 0.00
Biodesix (BDSX) United States $0.151B 0.00
So-Young (SY) China $0.104B 17.63
Ascend Wellness Holdings (AAWH) United States $0.086B 0.00
IceCure Medical (ICCM) Israel $0.072B 0.00
Oncology Institute (TOI) United States $0.067B 0.00
ModivCare (MODV) United States $0.062B 3.35
NeueHealth (NEUE) United States $0.061B 1.61
Singular Genomics Systems (OMIC) United States $0.050B 0.00
OncoCyte (OCX) United States $0.035B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.031B 0.00
Co-Diagnostics (CODX) United States $0.022B 0.00
Pheton Holdings (PTHL) China $0.019B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
KindlyMD (KDLY) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
XWELL (XWEL) United States $0.006B 0.00
Aclarion (ACON) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00